Pyrazinamide: all 40 studies that test it
Page 1 of 1. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.
- Re-evaluating the Duration in Children of TB TreatmentNot yet recruitingNCT07656012Phase 2
- AIPH-TB: AI-Optimised Pyrazinamide-Hydroxychloroquine vs Standard RIPE for Drug-Sensitive Pulmonary Tuberculosis - A Phase II RCTNot yet recruitingNCT07467252Phase 2
- Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)RecruitingNCT07163143Phase 3
- A PAN-USR TB Multi-Center TrialRecruitingNCT06905522Phase 3
- Platform Assessing Regimens and Durations In a Global Multisite Consortium for TBRecruitingNCT06114628Phase 2
- Intensified Short Course Regimen for TBM in AdultsNot yet recruitingNCT05917340Phase 3
- PanACEA - STEP2C -01RecruitingNCT05807399Phase 2
- Sitafloxacin-containing Regimens for Shortening Tuberculosis TreatmentNot yet recruitingNCT05454345Phase 3
- A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in ChinaRecruitingNCT05306223Phase 4
- Evaluating the Early Bactericidal Activity, Safety and Tolerability of Nebulised RESP301 in Adults With TuberculosisTerminatedNCT06041919Phase 2Results posted
- Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary TuberculosisTerminatedNCT05971602Phase 2Results posted
- Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary TuberculosisCompletedNCT05382312Phase 2Results posted
- A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary TuberculosisCompletedNCT04179500Phase 2Results posted
- Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult PatientsCompletedNCT03338621Phase 2/3Results posted
- Using Biomarkers to Predict TB Treatment DurationCompletedNCT02821832Phase 2Results posted
- Treatment Shortening of MDR-TB Using Existing and New DrugsCompletedNCT02619994Phase 2Results posted
- The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TBCompletedNCT02409290Phase 3Results posted
- Shortening Treatment by Advancing Novel DrugsCompletedNCT02342886Phase 3Results posted
- A Phase 2 to Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis.CompletedNCT02193776Phase 2Results posted
- Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With Clofazimine (C)-TMC207 (J)-PA-824 (Pa)-Pyrazinamide (Z)CompletedNCT01691534Phase 2Results posted
- Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002)CompletedNCT01498419Phase 2Results posted
- REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) TreatmentCompletedNCT01380080Phase 4Results posted
- Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With(J-M-Pa-Z) (NC-001)CompletedNCT01215851Phase 2Results posted
- Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary TuberculosisCompletedNCT00864383Phase 3Results posted
- Rifapentine Plus Moxifloxacin for Treatment of Pulmonary TuberculosisTerminatedNCT00728507Phase 2Results posted
- Tuberculosis Treatment Shortening TrialCompletedNCT00130247Phase 3Results posted
- Testing New Strategies for Patients Hospitalised With HIV-associated Disseminated TuberculosisActive, not recruitingNCT04951986Phase 3
- Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUSCompletedNCT04717908Not applicable
- Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and PyrazinamideSuspendedNCT04694586Phase 2
- Evaluating the EBA of Meropenem With Amoxicillin/Clavulanate and Pyrazinamide or Bedaquiline in Adults With PTBCompletedNCT04629378Phase 2
- Efficacy and Tolerability of Delamanid, Linezolid, Pyrazinamide and LevofloxacinWithdrawnNCT02975570Phase 3
- Evaluating Newly Approved Drugs for Multidrug-resistant TBCompletedNCT02754765Phase 3
- Whole Blood Bactericidal Activity Against Mycobacterium Tuberculosis of Pyrazinamide Plus Allopurinol in Healthy VolunteersCompletedNCT02700347Phase 1
- The Optimal Duration of Preoperative Anti-tuberculosis Treatment of Spinal TuberculosisStatus unknownNCT02477852Phase 4
- PK Study of Anti-TB DrugsCompletedNCT02457208Phase 1
- Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment OutcomesStatus unknownNCT01782950Phase 4
- Reintroduction Regimens After Hepatitis During Anti-tuberculosis TreatmentStatus unknownNCT01395654Phase 4
- Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat TuberculosisCompletedNCT00816426Phase 1
- Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated TuberculosisCompletedNCT00698334Phase 3
- TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or IntoleranceCompletedNCT00023374Not applicable